Citizen Petition from The Doctor Patient Forum

The Doctor Patient Forum supports the citizen petition to regulate or abolish the NarxCare system. They argue that the system lacks transparency, violates patient rights, and negatively impacts the ability of healthcare providers to deliver effective care.

The commenter, speaking as a representative of the chronically ill and pain patients, supports the petition by highlighting the suffering of patients who lack access to pain management. They argue that current regulations are discriminatory and push vulnerable people toward dangerous alternatives like overdose or suicide.

Beverly C. Schechtman, representing The Doctor Patient Forum, submits a citizen petition requesting that the FDA regulate NarxCare as a Software as a Medical Device (SaMD). The organization argues that NarxCare's risk-scoring algorithms lack transparency and clinical validation, leading to patient harm and restricted access to necessary medications.

The commenter supports the petition to regulate NarxCare as a "Software as a Device" to ensure transparency and oversight. They argue that the current proprietary algorithm used to deny pain medications lacks clinical input and creates risks of malpractice.

The commenter, a patient, argues that the Narxcare algorithm is causing physical and emotional harm by incorrectly penalizing patients for pharmacy stock issues. They urge the FDA to stop the use of this software, claiming it is a "barbaric algorithm" that endangers patient health.

An individual supports the petition because they are concerned that algorithms and scoring systems may lead to impersonal and potentially harmful healthcare decisions. They argue that medical care should prioritize human judgment and individualized attention over data-driven systems that lack transparency.

The commenter expresses concern regarding potential biases and the lack of transparency regarding certain healthcare entities and treatments. They argue that the current situation could prevent access to "Gold Standard" treatments and advocate for a closer look into issues like shortages and forced tapers.

The commenter supports the petition to regulate NarxCare as a Software as a Medical Device (SaMD). They argue that unregulated risk-scoring algorithms can negatively impact patient care and that FDA oversight is necessary to ensure safety, transparency, and clinical validation.

An individual patient expresses concern that an AI-generated risk score (Narx score) could unfairly bias medical treatment for patients on controlled medications. They also raise concerns regarding HIPAA privacy violations and the lack of nuance in how the algorithm accounts for specific medical histories.